Article
MiR-199 Aggravates Doxorubicin-Induced Cardiotoxicity by Targeting TAF9b
Evidence-Based Complementary and Alternative Medicine · 2022 · Yangsheng Yu, author Degang Guo, author Lin Zhao, author Zhaoqi Dong, Academic Editor
Key facts
| Title | MiR-199 Aggravates Doxorubicin-Induced Cardiotoxicity by Targeting TAF9b |
|---|---|
| First author | Yangsheng Yu, author Degang Guo, author Lin Zhao, author Zhaoqi Dong, Academic Editor |
| Journal | Evidence-Based Complementary and Alternative Medicine |
| Published | Mar 24, 2022 |
| DOI | 10.1155/2022/4364779 |
| Devices mentioned | DEN000008, K022086, K103302 |
| Product codes mentioned | JCI, KIP, KIT, NDS, NJT, OOI |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1